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Background: The soluble antigen preparation of adult schistosomes (SWAP) has often been used to probe host
responses against these blood-dwelling parasites. Despite its long-established use there is limited knowledge about
its composition. The information we provide here on the molecular composition of SWAP may contribute as a
guide for a rational selection of antigenic targets.
Methods: Label-free quantitative shotgun proteomics was employed to determine the composition and abundance of
SWAP constituents. Briefly, paired adult Schistosoma mansoni worms were sonicated in PBS pH 7.2 and ultracentrifuged
for recovery of the soluble supernatant. An aliquot was subjected to trypsin digestion. Resulting peptides were
separated under ultra-high performance liquid chromatography and analysed using an orbitrap mass spectrometer.
Spectral data were interrogated using SequestHT against an in-house S. mansoni database. Proteins were quantified by
recording the mean area under curve obtained for up to three most intense detected peptides. Proteins within the
90th percentile of the total SWAP mass were categorized according to their sub-cellular/tissue location.
Results: In this work we expanded significantly the list of known SWAP constituents. Through application of stringent
criteria, a total of 633 proteins were quantitatively identified. Only 18 proteins account to 50 % of the total SWAP mass
as revealed by their cumulative abundance. Among them, none is predicted as a secreted molecule reinforcing the
point that SWAP is dominated by cytosolic and cytoskeletal proteins. In contrast, only 3 % of the mass comprised
proteins proposed to function at the host-parasite interfaces (tegument and gut), which could conceivably represent
vulnerable targets of a protective immune response. Paradoxically, at least 11 SWAP proteins, comprising ~25 % of its
mass, have been tested as vaccine candidates.
Conclusions: Our data suggest that use of SWAP to probe host responses has greatest value for diagnostic purposes
or assessing intensity of infection. However, the preparation is of limited utility as an antigen source for investigating
host responses to proteins expressed at or secreted from worm-host interfaces. The data also pose the question as to
why vaccination with SWAP, containing so many proposed vaccine candidates, has no additive or even synergistic
effects on the induction of protection.
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SWAP (or SWA) is a soluble adult worm antigen
preparation universally used by immunologists to probe
host responses to schistosome infections. It is essentially
a Tris-HCl or PBS-based extract of mixed male and
female worms variously prepared by homogenization,
sonication or freeze/thaw (or a combination of these)
followed by a high-speed centrifugation to remove par-
ticulate material. It yields a solution typically containing
3-5 mg protein/mL which can be stabilized by adding
protease inhibitor cocktail for ELISA and Western
blotting or used without inhibitors for cell-stimulation
assays. The first report on its use appears to be from
1977 [1] and 38 years later it is still a standard prepar-
ation. In one recent publication SWAP was used to
investigate human anti-fecundity immunity to Schisto-
soma haematobium using antibody isotype ELISAs as
the assay of reactivity [2]. In a second study, a version of
SWAP supplemented by proteins soluble in chaotropic
agents and mild detergents provided the material for
an immunoproteomic analysis of human antibody re-
sponses, using 2D western blotting to select reactive
constituents [3].
In spite of this long-established usage very little is
known about its precise composition. The first prote-
omic study of S. mansoni, using 2D-gel technology and
peptide-mass fingerprinting, provided a comparison of
soluble preparations from four different life-cycle stages,
among them adult worms [4]. The 40 most abundant
spots from 2D gel comprised glycolytic enzymes (e.g
enolase, aldolase, GAPDH, TPI), cytoskeletal proteins
(actin, myosin light chain, tropomyosin), chaperones
(Hsp-70, 14-3-3), stress response proteins (superoxide
dismutase, GST-28) and calcium-binding proteins (cal-
ponin and EF-hand Sm21.7). However, no information
was provided on relative abundance of the components.
Peptide mass fingerprinting was superseded more than a
decade ago by peptide fragmentation as a more accurate
means of protein identification. Whilst gel technology is
still useful in some applications, for compositional studies
quantitative shotgun proteomics is now the method of
choice [5]. Furthermore, the advances in mass spec-
trometer design have increased the sensitivity of peptide
detection by orders of magnitude [6, 7].
Motivated by a feeling that immunologists really ought
to know exactly what they are probing their cell or anti-
body responses with when they use SWAP, we describe
here an analysis of its composition using state-of-the-art
instrumentation in conjunction with software for protein
identification and quantitation. We have shown that at
least 80 % of the identified molecules are primarily of
intracellular origin whereas only 3 % represent signature
proteins derived from the tegument and gastrodermis,
the major host-parasite interfaces. The information weprovide on the composition and abundance of SWAP
constituents should better enable immunologists to




The protocol for maintenance of the S. mansoni life cycle
was reviewed and approved by the local ethics committee
on animal experimentation, Comissão de Ética no Uso de
Animais (CEUA), Universidade Federal de Ouro Preto
(UFOP), and received the protocol no. 2011/55.
SWAP or (SWA) – soluble worm antigen preparation
Approximately 100 adult paired worms were sonicated
in 1 mL PBS pH 7.2 containing 1x Protease Inhibitor
Cocktail (Sigma Aldrich, St. Louis, USA). The homogenate
was clarified by centrifugation at 40,000 x g, for 2.5 h,
at 4 °C followed by recovery of the supernatant containing
soluble antigens. The protein content was determined
using PIERCE™ BCA Protein Assay Kit (Thermo Scientific,
Rockford, USA).
In solution digestion and mass spectrometry analysis
Proteins present in a 50 μg aliquot of SWAP were first
reduced using 2 mM dithiothreitol (Sigma Aldrich) at
56 °C, for 15 min, in 100 mM ammonium bicarbonate.
After cooling at room temperature, proteins were then
alkylated in 4.5 mM iodoacetamide (Sigma Aldrich) for
15 min in the dark. The sample was then diluted 2.5
times using ultra-pure water and the ammonium bicar-
bonate concentration adjusted to 100 mM. Protein
digestion was carried out at 37 °C for 16 h using
Sequencing Grade Modified Trypsin (Promega, Madison,
USA) at a protein to enzyme ratio of 25:1. Trypsinolysis
was terminated by sample acidification with 4 % (v/v)
ultra-pure glacial acetic acid (J.T. Baker, Center Valley,
USA). Peptides were cleaned up by solid phase extraction
using a Strata C18-E cartridge (55 μm, Phenomenex,
Macclesfield, UK).
LC-MS/MS analyses
Five μg of the peptide preparation were loaded onto
a UltiMate® 3000 UHPLC system (Thermo Scientific,
Bremen, Germany) equipped with an Acclaim PepMap100
C18 Nano-Trap Column (75 μm i.d. × 2 cm, 3 μm, 100 Å;
Thermo Scientific) in line with an Acclaim PepMap100
C18 RSLC (75 μm i.d. × 15 cm, 2 μm, 100 Å; Thermo
Scientific) capillary column. Trapped peptides were
washed for 3 min in 2 % (v/v) acetonitrile/0.05 % (v/v)
trifluoracetic acid, at a flow rate of 5 μL/min, before
switching the flow to the capillary column. Peptide
separation was carried out at 40 °C under a multi-step
gradient using a combination of solvents A (0.1 % (v/v)
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formic acid). The gradient started from 4 % solvent B,
increased to 30 % over 180 min and reached 55 % at
240 min. This was followed by a sharp ramp to 90 %
solvent B over 10 min, maintenance at 90 % for an add-
itional 10 min and finally a drop to 4 % over 20 min to
restore the initial condition. All UHPLC solvents were
purchased from J.T. Baker®.
A nano UHPLC system interfaced with a Q-Exactive™
instrument (Thermo Scientific) allowed the mass spec-
trometric analysis of eluting peptides. A Nanospray Flex
Ion Source (Thermo Scientific) fitted with a stainless
steel nano-bore emitter needle (150 μm o.d. × 30 μm
i.d., Proxeon, Thermo Scientific) was operated at 1.9 kV,
in positive mode and capillary temperature set to 250 °C.
Survey scans were acquired at a resolution of 70,000
with maximum injection time of 100 ms and target value
of 3 × 106 ions. Up to 12 most abundant isotope pat-
terns scanned in the range of 300-2000m/z, exhibiting
charge state ≥2 were isolated over a window of 2m/z
before fragmentation via higher-energy collisional dis-
sociation (HCD) with normalized collision energy of
30 V. MS/MS spectra were acquired at a 17,500
resolution with maximum injection time of 150 ms and
target value of 2 × 105 ions. Dynamic exclusion of ions
was set to 60 s.
Data processing
Mass spectral data were submitted to database search
using Proteome Discoverer software v.1.4 (Thermo
Scientific). Our workflow included the SequestHT search
engine plus Event Detector and Precursor Ions Area
Detector for label-free quantification. Searching parame-
ters included: 1) enzyme, trypsin/P; 2) maximum missed
cleavage sites = 2; 3) carbamidomethyl (C); 4) methio-
nine oxidation and N-terminal acetylation as dynamic
modifications; 5) mass tolerance of 10 ppm for parental
ions and 0.1 Da for MS/MS. Spectra were searched
against a local Schistosoma mansoni database (10,773 se-
quences; 5,135,674 residues). Only the protein identities
that matched to at least one high confidence peptide
were considered.
Protein categorization and bioinformatic analyses
Proteins were categorized by sub-cellular or tissue location
using data from the S. mansoni database, Uniprot, and
Blast searches. Signature proteins, here defined as known
constituents of the soluble, gut-secreted and tegument pro-
teomes, were listed based on published literature [4, 8–11].
Signal peptides were predicted using SignalP v3.0.
Statistical analysis
Arbitrary values related to individual protein abundance
were tested for normal distribution using the Shapiro-Wilktest by the GraphPad Prism version 5.00 for windows,
GraphPad software, San Diego, California, USA.
Results
Shotgun analysis revealed a large number of constituents
in SWAP
A total of 60,571 peptides, selected by the Q-Exactive
for fragmentation, yielded approximately 1000 identities
when the latest version of the S. mansoni gene predic-
tions was searched using Proteome Discoverer. We then
used the area under the curve of each fragmented pre-
cursor ion, recorded by the software, as the measure of
protein abundance. To ensure we did not eliminate low
mass proteins with few possible tryptic peptides (e.g
cyclophilin and ubiquitin) we included identities based
on a single peptide provided that the MS/MS spectrum
was of sufficient quality to guarantee a high confidence
score. This reduced the data for analysis to 633 proteins
at a false discovery rate of 1 %.
Abundance of SWAP constituents is not evenly
distributed
An intensity plot of the recorded area score for each
identified protein shows a markedly skewed distribution
with a relatively small number of proteins being highly
abundant and many present in only trace amounts
(Fig. 1a). The dynamic range of modern proteomic ana-
lysis was revealed by the highest (78,766) and lowest
(3.6) values in the 633 protein series, which differed by
more than four orders of magnitude. The proteins were
arranged in descending order by abundance to record
the cumulative total area, and the percentage contribution
of each determined (Fig. 1b). Twenty percent of the total
SWAP mass was contributed by only five proteins, namely
enolase, aldolase, actin, glyceraldehyde 3-phosphate de-
hydrogenase and fatty acid-binding protein (Table 1). Fifty
per cent of the total mass was represented by only 18
proteins and a further 149 made up 90 % of the total. The
remaining 10 % was accounted for by 467 proteins each
present in very small amounts. We chose to focus subse-
quent analyses on the 167 proteins that comprise the bulk
of the mass up to the 90th percentile. Proteomic analyses
of other systems have revealed that the log concentration
of protein abundance displays a normal distribution. Our
SWAP preparation (Fig. 1c) appears visually skewed to-
wards the more abundant components so we tested its
normality using Shapiro-Wilk test proving a non-Gaussian
distribution (p = 0.016).
SWAP constituents are heavily biased towards cytosol
and cytoskeleton
We first searched the total dataset for matches to signa-
ture proteins identified by our previous proteomic inves-
tigations, color-coding the observed similarities. Sixteen
Fig 1 Protein distribution in SWAP. a Protein abundance of SWAP
determined using the absolute Area Under Curve (AUC) values
recorded for each of the 633 proteins identified. Note that a very
small number of proteins contributed to the most prominent MS
peaks detected. b Protein abundance in SWAP represented as a
cumulative frequency plot revealed that only 18 constituents
contributed to 50 % of the total mass. c Frequency distribution
plotted after Log2 transformation of the calculated AUC for each
protein. Although the distribution superficially appears Gaussian, a
Shapiro-Wilk test revealed that it is not (p < 0.05), high abundance
proteins being over-represented
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were equally prominent in our cytosolic fraction, many
of them occupying the top positions in both studies.
Approximately half the proteins identified as constituents
of the worm vomitus were detected; these were almost
exclusively the hydrolytic enzymes not the transporterproteins. Only seven out of 61 verified tegument surface
proteins were present in SWAP, with three, Sm200, Sm29
and an annexin within the 90th percentile. We then
grouped each one of the 167 top proteins by sub-
cellular or tissue location, by manual searching of
several databases. Ten putative proteins were unusable
or they were hypothetical, not yielding a meaningful
annotation after BLAST searching of NCBInr, and were
transferred to the residual unclassified category. These
were approximately balanced by adding the known gut
and tegument proteins in the bottom 467 identities.
The color-coded proteins were then sorted by function/
tissue category and the total mass contributed by each
group illustrated in a pie-chart (Fig. 2).
The largest category by far (~60 %) comprises intracel-
lular proteins from the cytosol. They function principally
in glycolysis, protein translation, protein folding and the
response to stress, all classical housekeeping activities.
The second largest category (14 %) comprises proteins
of the cytoskeleton and associated proteins, many of
which will be present in the musculature. We classified
calcium-binding proteins as a separate category (8 %)
since they are found in many cellular locations and
tissues like the tegument. Although mitochondria and
nuclei are abundant cellular constituents, proteins ori-
ginating therein comprised only 2.5 and 2 % of the total,
respectively. The few mitochondrial proteins appear to
come from the matrix, likely released upon sonication
(Additional file 1). The total mass contribution of tegu-
ment and gut proteins amounts to only 3 %. Further
small contributions of protein are made by extracellular
matrix, the secretory pathway and glycogen metabolism,
this last representing parenchymal tissue.
A small number of proteins comprise half the mass
A detailed consideration of the top 18 proteins compris-
ing half the total mass revealed that all were intracellular
with only one (Smp_049550, 78 kDa glucose regulated
protein; Table 1) possessing a signal peptide (p = 0.999).
However, this protein is a Hsp-70 family member in-
volved in protein folding and localized to the lumen of
the endoplasmic reticulum. The remaining 17 proteins
are all located in the cytosol rather than in an organelle
and so unlikely to be N- or O- glycosylated for export
(Table 1). When grouped by cellular function the five
enzymes involved in energy metabolism (Table 1, EM)
accounted for 39 %, and the four chaperones (CH) for
22 %. The two cytoskeletal proteins (CY) comprise 13 %,
the three calcium-binding proteins 10 % and the two
stress-response proteins (SR) 9 %. Fatty acid-binding
protein, involved in intracellular lipid transport (ILT),
made up the final 7 %. The abundance of all these pro-
teins, apart from cyclophilin, is confirmed by the large
number of diagnostic peptides (range 4-17, mean 8.4)
Table 1 Top 18 most abundant proteins representing half of the total mass in SWAP
Gene DB Accession Description Class # of Peptides % Coverage PD Areaa MW[kDa] % total SWAP Homo sapiens Accession % Identity % Cons. Signal peptide
Smp_024110.1 Enolase EM 12 33,4 78,766 47,0 6,1 NP_001419.1 75 86 no
Smp_042160.1 Aldolase EM 11 27,2 66,915 35,4 5,2 NP_005156.1 69 80 no
Smp_161930.1 Actin CY 7 30,3 62,296 35,5 4,8 gb|AAP37280.1 67 71 no
Smp_056970.1 Glyceraldehyde 3 P dehydrogenase EM 6 25,7 48,106 36,4 3,7 NP_002037.2 73 82 no
Smp_095360.1 Fatty acid-binding protein, Sm14 ILT 4 39,9 42,434 14,8 3,3 gb|AAB87141.1 47 61 no
Smp_054160.1 Glutathione S-transferase, GST 28 SR 7 42,7 39,378 23,8 3,1 AAA58623.1 30 48 no
Smp_106930.1 Heat shock 70 kDa protein CH 17 29,7 32,378 69,8 2,5 NP_006588.1 84 92 no
Smp_050390.1 Aldehyde dehydrogenase EM 11 31,4 32,212 53,7 2,5 gb|AAH01619.1 57 72 no
Smp_009760.1 14-3-3 protein zeta/delta CH 6 24,6 31,822 28,4 2,5 NP_003397.1 64 74 no
Smp_040130.1 Cyclophilin CH 1 8,70 30,114 17,6 2,3 AAH05982.1 67 73 no
Smp_034840.1 14-3-3 protein epsilon CH 11 48,0 24,916 26,0 1,9 NP_006752.1 65 82 no
Smp_086330.1 Calponin CB 7 44,2 23,786 21,2 1,8 XP_006722711.1 47 64 no
Smp_183710.1 Actin CY 7 27,7 21,927 41,7 1,7 NP_001092.1 96 99 no
Smp_049550.1 78 kDa glucose regulated protein CH 15 25,0 20,302 71,2 1,6 NP_005338.1 75 87 yes
Smp_045200.1 Tegument-allergen-like protein Sm22.6 CB 5 25,8 19,594 22,6 1,5 pdb|2PMY|A 29 50 no
Smp_008070.1 Thioredoxin SR 7 71,7 19,167 11,9 1,5 NP_003320.2 47 61 no
Smp_086530.1 Tegument-allergen-like protein Sm20.8 CB 7 47,0 18,922 20,8 1,5 BAD97069.1 22 49 no
Smp_096760.1 Phosphoglycerate mutase EM 10 50,0 17,642 28,4 1,4 NP_000281.2 57 71 no
Means 8,4 35,2 35,038 33,7 2,7 60 72
Annotations in italics were added by the authors
EM Energy metabolism, CY Cytoskeletal, ILT Intracellular lipid transport, SR Stress response, CH Chaperone, CB Calcium binding












Fig 2 Sub-cellular or tissue location of SWAP constituents. Proteins within the 90th percentile were categorized according to published literature,
Uniprot and Blast searches. Soluble cytosolic and cytoskeletal proteins contribute to over 70 % of total abundance in SWAP. Conversely, proteins
proposed to function at host-parasite interfaces (e.g gut secreted and tegument surface) account for only 3 % of the total mass
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sequence coverage (range 9-72 %). All the top 18 iden-
tities are medium-sized proteins (range 12-71 kDa,
mean 33.7 kDa). Fifteen out of 18 proteins have close
homology in the human host (mean 66 %), the three
exceptions being the EF-hand calcium-binding proteins
Sm22.6 and Sm20.8 and glutathione S-transferase 28
(mean 27 %). It is notable that, at least three proteins in
the first group and two in the second have been pro-
posed as vaccine candidates.
Discussion
In this study we have provided the first inventory of
SWAP constituents using a shotgun-based proteomic
approach. The applied methodology combines high-
resolution liquid chromatography for peptide separation
coupled to accurate m/z detection of eluting molecules
using a mass spectrometer. Compared to the classic 2D
gel technique, shotgun analysis allows for detection of
proteins with a wide dynamic range, differing in abun-
dance by several orders of magnitude. In addition to
protein identification, the shotgun strategy is also cap-
able of estimating protein abundance through peak area
detection of a precursor ion, using either tag-modified
peptides [12], SILAC [13] or label-free methods [14, 15].The last alternative requires minimal sample handling
and can be applied to any detectable peptide, excluding
the need for chemical tagging at specific amino acid
residues. Here we have applied a stringent criterion for
peptide selection, and hence protein identification, to
gain insight into the relative abundance of the major
constituents of the SWAP preparation. This approach
increased significantly the repertoire of soluble worm
protein constituents first described in 2004 using 2D gel
electrophoresis [4].
Protein categorization revealed a preparation largely
containing intracellular constituents that accounted for
97 % of the identities. In the context of schistosome
biology, this large fraction of proteins will only trigger
immune effector mechanisms of the vertebrate host
when parasite larvae, adult worms or eggs are damaged
or die, releasing their cytosol into the host bloodstream
or tissues. By extension, the protein constituents of
SWAP are unlikely to be targets of a protective immune
response because they are largely confined within the
cells of live parasites. In stark contrast, proteins
expressed at the host-parasite interfaces (namely the
tegument and alimentary tract) are for the most part
scarce or undetectable in SWAP accounting for only
approximately 3 % of the total mass. In the case of
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were putative constituents of the membranocalyx namely
Sm200, an annexin, CD59 and Sm29 [10, 11]. Concerning
the last of these, its recorded relative abundance was too
small to be included in the 90th percentile of SWAP con-
stituents. Annexin aside, the other three proteins Sm200,
CD59 and Sm29 are known to be GPI-anchored [11], and
their presence in SWAP could be explained by physical
extraction of such membrane proteins during sample
homogenization. Based on the aforementioned percent-
ages it is clear that when SWAP is used to probe host
cellular or antibody responses, the fraction of these attrib-
utable to surface-exposed or secreted proteins is negli-
gible. It is noteworthy to mention we only considered
secretion/excretion of proteins by means of the classical
secretory pathway. Previous studies performed in vitro re-
ported the production of vesicles by schistosomes [16, 17]
and exosome-like particles being formed in the tegument
of other parasitic helminths (Echinostoma caproni and
Fasciola hepatica) [18]. However, compositional analysis
of the S. mansoni culture’s supernant and the lipidome of
the host’s blood plasma did not indicate the release of
phospholipids known to be enriched at the parasite’s tegu-
ment surface [19]. Identification of such lipids would
argue in favour of genuinely secreted exosomes. Thus, to
our understanding prediction of signal peptide remains
the most convenient approach to anticipate protein secre-
tion by S. mansoni.
We tacitly acknowledged this limitation of SWAP in
our study of rhesus macaque self-cure responses [20]
where we developed two specific antigen fractions, SASP
(Stimulated Adult Worm Secreted Preparation) and TSP
(Tegument Surface Preparation), to investigate reactivity
to gut and tegument constituents, respectively, by West-
ern blotting. At least two major conclusions could be
drawn from these macaque experiments. First, only low
burden animals exhibited high antibody titers against
those antigens. A major fraction of the reactive spots
could not be easily visualized using high sensitivity stain-
ing methods of the corresponding replica gels, suggest-
ing that likely protective antibodies are targeting minor
components of the preparations. Second, particularly for
the tegument enriched preparation, the complexity of
serum reactivity is inversely proportional to final worm
burden. It follows that any similar studies wishing to
investigate host responses to proteins expressed at or
secreted from interfaces will have limited utility if SWAP
is used as the only antigen source.
SWAP preparations have been used for vaccination
experiments in past decades with variable results [21, 22].
The most consistent results were obtained in an extensive
series of experiments where 1 mg of SWAP was adminis-
tered intradermally to mice along with 5 × 106 units of
BCG [23, 24]. The BCG alone elicited no protection whilstSWAP alone produced a small non-significant effect [25].
Paramyosin, a muscle protein was the major immunogen
detected by antibodies from vaccinated animals although
paradoxically this group of researchers concluded that the
40-50 % protection achieved was based on T cell-mediated
mechanisms involving interferon gamma production
by T cells and activation of macrophages, not humoral
responses [25]. Paramyosin is #46 in our SWAP pre-
paration by abundance, equating to 0.4 % of the total
protein or 4.4 μg/mg. This is exactly in the range
of affinity-purified paramyosin subsequently used to
achieve ~40 % protection in mice with BCG as adjuvant
[26]. In this same publication the authors note that the
SWAP-depleted of paramyosin still possessed protective
properties. This leads us directly to the observation that
many of the most abundant constituents of our SWAP
from S. mansoni (or S. japonicum) have been administered
to mice to induce protective immunity.
A search of the literature reveals that these candidates
include aldolase (#2), GAPDH (#4), fatty acid-binding
protein (#5), GST-28 (#6), 14-3-3 (#9), calponin (#12),
Sm22.6 (#15) and Sm20.8 (#17) [27–34] with levels of
protection ranging from 30 to 50 %. The respective
abundance of these proteins in 1 mg of our SWAP prep-
aration is 52, 37, 33, 31, 25, 18, 15 and 15 μg, collectively
amounting to 226 μg. If we add in other proposed candi-
dates such as Cu/Zn superoxide dismutase [35] (#21,
15.3 μg), myosin heavy chain [36] (#32, 6 μg) and pro-
tein disulphide isomerase [37] (#34, 5.8 μg) it is clear
that at least a quarter of SWAP by mass comprises puta-
tive vaccine candidates. However, there is clearly no
additive effect when all these candidates are adminis-
tered together as the SWAP cocktail. Indeed, this is an
odd and unexplained feature of the protection induced
in mice by what are almost entirely cytosolic and cyto-
skeletal (i.e. internal) candidates. It seems each must be
triggering the same mechanism to approximately the
same degree but the outcome always hits a ceiling of
approximately 40 % protection whether the antigen is
given alone or en masse via SWAP. We intend to ad-
dress this conundrum in a separate publication.
The choice of SWAP to probe host responses is prag-
matic because it is easy to prepare, the yields of soluble
protein are high and due to the intrinsic immunogenicity
of its major constituents, it virtually guarantees a strong
response in assays. However, our data suggest that this
last point is a trap for the experimenter. The principal
components we have identified have been termed cryptic
antigens [2] because they are only released when the
adult worm dies. Proteomic analysis has revealed a
similar mixture of soluble proteins in the eggs that are
deposited and die in the tissues [4, 38] so that the host
will be continuously restimulated by major SWAP con-
stituents throughout the course of an infection. It is
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classes of antigens not particularly dealt with in this
shotgun approach. Anyhow, lipids and glycolipids are
unlikely to be enriched in SWAP as no organic solvents
(e.g methanol-chloroform) are used during its prepar-
ation. In addition, we cannot rule out the possibility that
identification of glycoproteins has been made in this
study. This can be achieved by identification and quanti-
tation of non-glycosylated tryptic peptides.
Recently, the rate of evolution of schistosome proteins
has been investigated using the dN/dS ratio of nucleo-
tide substitutions as the criterion of selection pressure, in
the three major schistosome species that infect humans
[39]. The study revealed that genes encoding exposed
micro-exon gene (MEG) proteins and some venom
allergen-like (VAL) proteins had the highest ratios, com-
pared to genes encoding internal proteins and gastro-
dermal secretions. This applied even to those proteins
at the tegument surface, apart from two surface vaccine
candidates, Sm29 and the extrinsic portion of tetraspa-
nin TSP-2, which also had high dN/dS ratios. These
data indicate that there is a definitive tendency in the
Genus Schistosoma for truly exposed antigens to diver-
sify due to selection pressure, whereas the cryptic
antigens vary much less. A strong immune response is
mounted against the cryptic antigens when they are
encountered, but cannot provide effective protection.
Thus, survival of a schistosome population, and adapta-
tion to new hosts, requires an evolutionary response
that modifies exposed epitopes to extend longevity
and facilitate worm reproduction. Paradoxically, while
estimation of the dN/dS ratio provides an indicator of
diversification, by extension it also reveals that the
existing parasite population has been able to accommo-
date the hostile response. Our compositional analysis of
SWAP, in which the highly modified MEGs and VALs
proteins are barely detectable, suggests that its use to
probe host responses to find vaccine candidates is
almost certain to point the researcher in the wrong dir-
ection. Furthermore, where major SWAP components
(or SWAP itself ) have been tested in vaccination experi-
ments the ~40 % protection observed has some rational
explanation other than specific acquired immunity.
Conclusion
In this work we conducted a quantitative shotgun prote-
omic analysis of SWAP greatly expanding the list of its
constituents. Our data have shown that at least 80 % of
the identified molecules are primarily of intracellular
origin whereas only 3 % represent signature proteins
derived from the tegument and gastrodermis, the major
host-parasite interfaces. This finding should allow im-
munologists to appreciate the dominant targets of the
host cellular and antibody responses they are monitoringwhen SWAP is used as an antigenic preparation. This
study finally poses the question as to why vaccination
with SWAP, containing so many proposed vaccine
candidates, has not shown additive or even synergistic
effects on the induction of protection.
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